5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
|
- $32 - $2483
- Product name: 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
- CAS: 1225037-39-7
- MF: C17H20F3N7O2
- MW: 411.38
- EINECS:-0
- MDL Number:MFCD28902193
- Synonyms:5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine;PI3K-IN-2;PQR309 Bimiralisib;CS-2024;PQR309;PQR 309;PQR-309;Bimiralisib (PQR309)(free base);PQR-309, >98%;2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-
48 prices
Selected condition：
Brand
- aablocks
- ACHEMBLOCK
- AK Scientific
- Cayman Chemical
- ChemScene
- Crysdot
- DC Chemicals
- TRC
Package
- 1mg
- 2mg
- 2.5mg
- 5mg
- 10mM*1mLinDMSO
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- Manufactureraablocks
- Product numberAA009CGU
- Product description2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 98%
- Packaging25mg
- Price$104
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA009CGU
- Product description2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- ≥98%
- Packaging50mg
- Price$200
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA009CGU
- Product description2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 97%
- Packaging100mg
- Price$341
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA009CGU
- Product description2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 97%
- Packaging250mg
- Price$724
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA009CGU
- Product description2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 97%
- Packaging1g
- Price$2483
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA009CGU
- Product description2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 98%
- Packaging10mg
- Price$52
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA009CGU
- Product description2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 98%
- Packaging5mg
- Price$32
- Updated2026-05-28
- Buy
- ManufacturerACHEMBLOCK
- Product numberO33855
- Product descriptionPQR-309 98%
- Packaging25MG
- Price$295
- Updated2026-05-27
- Buy
- ManufacturerACHEMBLOCK
- Product numberO33855
- Product descriptionPQR-309 98%
- Packaging25MG
- Price$295
- Updated2026-05-25
- Buy
- ManufacturerACHEMBLOCK
- Product numberO33855
- Product descriptionPQR-309 98%
- Packaging100MG
- Price$695
- Updated2026-05-25
- Buy
- ManufacturerACHEMBLOCK
- Product numberO33855
- Product descriptionPQR-309 98%
- Packaging100MG
- Price$695
- Updated2026-05-27
- Buy
- ManufacturerACHEMBLOCK
- Product numberO33855
- Product descriptionPQR-309 98%
- Packaging250MG
- Price$1495
- Updated2026-05-25
- Buy
- ManufacturerACHEMBLOCK
- Product numberO33855
- Product descriptionPQR-309 98%
- Packaging250MG
- Price$1495
- Updated2026-05-27
- Buy
- ManufacturerAK Scientific
- Product number0926DP
- Product descriptionBimiralisib
- Packaging10mg
- Price$421
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number23441
- Product descriptionBimiralisib ≥98%
- Packaging25mg
- Price$702
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number23441
- Product descriptionBimiralisib ≥98%
- Packaging25mg
- Price$638
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA009CGU | 2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 98% | 25mg | $104 | 2026-05-28 | Buy |
| aablocks | AA009CGU | 2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- ≥98% | 50mg | $200 | 2026-05-28 | Buy |
| aablocks | AA009CGU | 2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 97% | 100mg | $341 | 2026-05-28 | Buy |
| aablocks | AA009CGU | 2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 97% | 250mg | $724 | 2026-05-28 | Buy |
| aablocks | AA009CGU | 2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 97% | 1g | $2483 | 2026-05-28 | Buy |
| aablocks | AA009CGU | 2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 98% | 10mg | $52 | 2026-05-28 | Buy |
| aablocks | AA009CGU | 2-Pyridinamine,5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)- 98% | 5mg | $32 | 2026-05-28 | Buy |
| ACHEMBLOCK | O33855 | PQR-309 98% | 25MG | $295 | 2026-05-27 | Buy |
| ACHEMBLOCK | O33855 | PQR-309 98% | 25MG | $295 | 2026-05-25 | Buy |
| ACHEMBLOCK | O33855 | PQR-309 98% | 100MG | $695 | 2026-05-25 | Buy |
| ACHEMBLOCK | O33855 | PQR-309 98% | 100MG | $695 | 2026-05-27 | Buy |
| ACHEMBLOCK | O33855 | PQR-309 98% | 250MG | $1495 | 2026-05-25 | Buy |
| ACHEMBLOCK | O33855 | PQR-309 98% | 250MG | $1495 | 2026-05-27 | Buy |
| AK Scientific | 0926DP | Bimiralisib | 10mg | $421 | 2021-12-16 | Buy |
| Cayman Chemical | 23441 | Bimiralisib ≥98% | 25mg | $702 | 2026-04-30 | Buy |
| Cayman Chemical | 23441 | Bimiralisib ≥98% | 25mg | $638 | 2024-03-01 | Buy |
Properties
Boiling point :643.7±65.0 °C(Predicted)
Density :1.418±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMSO:22.0(Max Conc. mg/mL);53.48(Max Conc. mM)
DMF:10.0(Max Conc. mg/mL);24.31(Max Conc. mM)
Ethanol:2.0(Max Conc. mg/mL);4.86(Max Conc. mM) form :A crystalline solid
pka :4.92±0.10(Predicted)
color :White to gray
Density :1.418±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMSO:22.0(Max Conc. mg/mL);53.48(Max Conc. mM)
DMF:10.0(Max Conc. mg/mL);24.31(Max Conc. mM)
Ethanol:2.0(Max Conc. mg/mL);4.86(Max Conc. mM) form :A crystalline solid
pka :4.92±0.10(Predicted)
color :White to gray
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
Bimiralisib is a potent and orally bioavailable inhibitor of phosphatidylinositol 3-kinases (PI3Ks; IC50s = 33, 661, 708, and 451 nM for PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, respectively) and the mammalian target of rapamycin (mTOR; IC50 = 89 nM). It is selective for these kinases over a panel of cell surface and nuclear receptors, membrane channels, transporters, kinases, proteases, and phosphodiesterases at a concentration of 10 μM. Bimiralisib has anticancer activity with an average GI50 value of 0.7 μM across the National Cancer Institute (NCI) 60 human cancer cell line panel. In vivo, bimiralisib (5-15 mg/kg) reduces tumor growth in a dose-dependent manner in a PC3 prostate cancer mouse xenograft model. Formulations containing bimiralisib are under clinical investigation for the treatment of relapsed and refractory lymphoma and advanced solid tumors.Related product price
-
196868-63-0
$17-2395.3 -
PPQ-102
$12-1600
Suppliers and manufacturers
ATK CHEMICAL COMPANY LIMITED
TargetMol Chemicals Inc.
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Zhejiang J&C Biological Technology Co.,Limited
InvivoChem
ShenZhen Trendseen Biological Technology Co.,Ltd.
Zibo Hangyu Biotechnology Development Co., Ltd
HANGZHOU LEAP CHEM CO., LTD.
Aladdin Scientific
